Brian DeCant

561 total citations
13 papers, 458 citations indexed

About

Brian DeCant is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Brian DeCant has authored 13 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 3 papers in Hematology. Recurrent topics in Brian DeCant's work include Pancreatic and Hepatic Oncology Research (8 papers), Multiple Myeloma Research and Treatments (3 papers) and TGF-β signaling in diseases (3 papers). Brian DeCant is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Multiple Myeloma Research and Treatments (3 papers) and TGF-β signaling in diseases (3 papers). Brian DeCant collaborates with scholars based in United States, Canada and Spain. Brian DeCant's co-authors include Paul J. Grippo, Hidayatullah G. Munshi, Daniel R. Principe, Andrew M. Diaz, Rosa F. Hwang, Barbara Jung, Emman Mascariñas, David J. Bentrem, William O. Dawson and Boris Pasche and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Brian DeCant

13 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian DeCant United States 10 295 227 107 87 66 13 458
Stéphanie Duhamel Canada 10 159 0.5× 243 1.1× 114 1.1× 72 0.8× 43 0.7× 18 448
Martina Brandl Germany 9 273 0.9× 354 1.6× 82 0.8× 96 1.1× 29 0.4× 12 527
Kelly E. Craven United States 9 204 0.7× 233 1.0× 61 0.6× 125 1.4× 44 0.7× 15 441
Feda H. Hamdan United States 16 146 0.5× 326 1.4× 54 0.5× 103 1.2× 56 0.8× 25 507
Eslam A. Elghonaimy Egypt 11 273 0.9× 241 1.1× 130 1.2× 103 1.2× 23 0.3× 18 511
Purvaba J. Sarvaiya United States 7 237 0.8× 154 0.7× 143 1.3× 91 1.0× 21 0.3× 8 415
Janani Kumar Australia 9 204 0.7× 215 0.9× 70 0.7× 109 1.3× 17 0.3× 10 433
Rémi Samain France 9 347 1.2× 311 1.4× 153 1.4× 141 1.6× 38 0.6× 12 641
Per Lund Germany 9 153 0.5× 258 1.1× 70 0.7× 126 1.4× 29 0.4× 9 453
Irina Abécassis United States 6 186 0.6× 147 0.6× 154 1.4× 80 0.9× 25 0.4× 7 371

Countries citing papers authored by Brian DeCant

Since Specialization
Citations

This map shows the geographic impact of Brian DeCant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian DeCant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian DeCant more than expected).

Fields of papers citing papers by Brian DeCant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian DeCant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian DeCant. The network helps show where Brian DeCant may publish in the future.

Co-authorship network of co-authors of Brian DeCant

This figure shows the co-authorship network connecting the top 25 collaborators of Brian DeCant. A scholar is included among the top collaborators of Brian DeCant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian DeCant. Brian DeCant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Pham, Thao D., Krishan Kumar, Brian DeCant, et al.. (2018). Induction of MNK Kinase–dependent eIF4E Phosphorylation by Inhibitors Targeting BET Proteins Limits Efficacy of BET Inhibitors. Molecular Cancer Therapeutics. 18(2). 235–244. 19 indexed citations
2.
Ebine, Kazumi, Krishan Kumar, Thao D. Pham, et al.. (2018). Interplay between interferon regulatory factor 1 and BRD4 in the regulation of PD-L1 in pancreatic stellate cells. Scientific Reports. 8(1). 13225–13225. 30 indexed citations
3.
Ding, Yongzeng, Bhargava Mullapudi, Carolina Torres, et al.. (2018). Omega-3 Fatty Acids Prevent Early Pancreatic Carcinogenesis via Repression of the AKT Pathway. Nutrients. 10(9). 1289–1289. 33 indexed citations
4.
Kumar, Krishan, Brian DeCant, Paul J. Grippo, et al.. (2017). BET inhibitors block pancreatic stellate cell collagen I production and attenuate fibrosis in vivo. JCI Insight. 2(3). e88032–e88032. 45 indexed citations
5.
Principe, Daniel R., Andrew M. Diaz, Carolina Torres, et al.. (2017). TGFβ engages MEK/ERK to differentially regulate benign and malignant pancreas cell function. Oncogene. 36(30). 4336–4348. 57 indexed citations
6.
Schultz, Michelle, Andrew M. Diaz, Brian DeCant, et al.. (2017). Thioredoxin system-mediated regulation of mutant Kras associated pancreatic neoplasia and cancer. Oncotarget. 8(54). 92667–92681. 7 indexed citations
7.
Principe, Daniel R., Brian DeCant, Emman Mascariñas, et al.. (2016). TGFβ Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis. Cancer Research. 76(9). 2525–2539. 156 indexed citations
8.
Principe, Daniel R., Brian DeCant, Jonas J. Staudacher, et al.. (2016). Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation. Oncotarget. 8(3). 3826–3839. 39 indexed citations
9.
Ebine, Kazumi, Christina R. Chow, Brian DeCant, et al.. (2016). Slug inhibits pancreatic cancer initiation by blocking Kras-induced acinar-ductal metaplasia. Scientific Reports. 6(1). 29133–29133. 5 indexed citations
10.
Diaz, Andrew M., Daniel R. Principe, Brian DeCant, et al.. (2016). Abstract 4178: Pigs as a new weapon against cancer: Modeling solid tumors in porcine. Cancer Research. 76(14_Supplement). 4178–4178. 2 indexed citations
11.
Principe, Daniel R., Brian DeCant, Andrew M. Diaz, et al.. (2016). PEDF inhibits pancreatic tumorigenesis by attenuating the fibro-inflammatory reaction. Oncotarget. 7(19). 28218–28234. 25 indexed citations
12.
Grippo, Paul J., Daniel R. Principe, Emman Mascariñas, et al.. (2015). Characterization of Mouse Models of Early Pancreatic Lesions Induced by Alcohol and Chronic Pancreatitis. Pancreas. 44(6). 882–887. 23 indexed citations
13.
DeCant, Brian, Daniel R. Principe, Carmen Guerra, Marina Pasca di Magliano, & Paul J. Grippo. (2014). Utilizing past and present mouse systems to engineer more relevant pancreatic cancer models. Frontiers in Physiology. 5. 464–464. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stéphanie Duhamel Breakdown of academic impact, for papers by Martina Brandl Breakdown of academic impact, for papers by Kelly E. Craven Breakdown of academic impact, for papers by Feda H. Hamdan Breakdown of academic impact, for papers by Eslam A. Elghonaimy Breakdown of academic impact, for papers by Purvaba J. Sarvaiya Breakdown of academic impact, for papers by Janani Kumar Breakdown of academic impact, for papers by Rémi Samain Breakdown of academic impact, for papers by Per Lund Breakdown of academic impact, for papers by Irina Abécassis
Rankless by CCL
2026